(Q81476468)

English

Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project

scientific article published on 01 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: observation and clinical implications from Tyrol screening project (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

prostate cancer

1 reference

based on heuristic

inferred from title

Ashutosh Tewari

2

object named as

Ashutosh Tewari

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alexandre E Pelzer

1

object named as

Alexandre E Pelzer

1 reference

Europe PubMed Central

PubMed publication ID

9 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

3

object named as

Jasmin Bektic

1 reference

Europe PubMed Central

PubMed publication ID

9 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

author name string

Andreas P Berger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ferdinand Frauscher

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Georg Bartsch

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Wolfgang Horninger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

66

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1029-1033

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prostate cancer screening in Tyrol, Austria: experience and results

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Patterns of progression in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prostate-specific antigen levels from completely sectioned, clinically benign, whole prostates

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Serendipity in detecting disease in low prostate-specific antigen ranges.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Characteristics of prostate cancers detected at low PSA levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.05.025

7 January 2021

Identifiers

10.1016/J.UROLOGY.2005.05.025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16286118%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81476468&oldid=2116022806"